# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Rosenblatt analyst Kevin Cassidy maintains Canaan (NASDAQ:CAN) with a Buy and maintains $4 price target.
BTIG analyst Justin Zelin reiterates Canaan (NASDAQ:CAN) with a Buy and maintains $8 price target.
Rosenblatt analyst Kevin Cassidy maintains Canaan (NASDAQ:CAN) with a Buy and maintains $4 price target.
SINGAPORE, Oct. 13, 2025 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in ...